Global Infection Surveillance Solutions Market Size, Share, Growth Report 2032

Infection Surveillance Solutions Industry Perspective

What will be the global infection surveillance solutions market size during the forecast period?

The global infection surveillance solutions market size was worth around USD 672.03 million in 2023 and is predicted to grow to around USD 2185.41 million by the end of 2032, with a compound annual growth rate (CAGR) of roughly 14.00% between 2024 and 2032. 

The report examines the primary drivers, challenges, and restraints shaping global demand for the infection surveillance solutions market throughout the forecast period and identifies high-growth opportunities across the industry.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global Infection Surveillance Solutions market is estimated to grow annually at a CAGR of around 14% over the forecast period (2024-2032).
• In terms of revenue, the global Infection Surveillance Solutions market size was valued at around USD 672.03 million in 2023 and is projected to reach USD 2185.41 million by 2032.
• The market is driven by the high incidence of healthcare-acquired infections, elevated mortality and morbidity rates, increasing antimicrobial resistance, growing use of automation in healthcare, and regulatory emphasis on infection control and patient safety.
• Based on the Product and Services, the Software segment is expected to register the highest growth rate, supported by demand for real-time analysis
• Based on the Type, the Urinary Tract Infections (UTI) segment is estimated to hold a substantial share due to the high prevalence of these infections in healthcare settings
• Based on the End-user, the Hospitals segment held the dominant share and is anticipated to exhibit strong growth
• By region, North America dominated the market due to its advanced healthcare infrastructure and high adoption of healthcare IT solutions

Infection Surveillance Solutions Market: Overview

The programs that help with the effective management of healthcare-acquired infections in healthcare facilities are recognized as infection surveillance solutions programs. Surveillance is an essential component of effective infection prevention and control programs. Surveillance data decreases the incidence of infections by identifying risk factors, executing risk-reduction actions, and monitoring the effectiveness of interventions.

The high incidence rate of healthcare-acquired infections is the main concern for governments worldwide, apart from being the major factor that is driving the global infection surveillance solutions market. Another major growth driver of the infection surveillance solutions market globally is the high mortality and morbidity rates caused by rising healthcare-acquired infection prevalence. Moreover, the increasing microbe resistance to antibiotics and the growing use of automation in the healthcare setting are also likely to accelerate the global infection surveillance solutions market growth over the forecast time period.

Infection Surveillance Solutions Market: Growth Drivers

What factors are accelerating the expansion of the Infection Surveillance Solutions market?

The persistently high incidence of healthcare-acquired infections remains the central growth driver, as these infections continue to impose significant clinical and economic burdens on healthcare systems worldwide. Elevated mortality and morbidity rates associated with HAIs, combined with increasing antimicrobial resistance, intensify the need for robust surveillance capabilities that can identify risks early and support targeted interventions.

Regulatory mandates and government initiatives requiring infection surveillance programs in hospitals and other facilities further accelerate adoption. Technological advancements, including artificial intelligence, data analytics, and integration with electronic health records, enable real-time monitoring, early outbreak detection, and more efficient infection control programs, driving broader market uptake.

Infection Surveillance Solutions Market: Restraints

What factors are limiting the growth of the Infection Surveillance Solutions market?

High implementation and ongoing maintenance costs represent a significant barrier, particularly for small and medium-sized healthcare facilities operating under constrained budgets. Limited financial and human resources often delay or prevent investment in advanced surveillance systems.

Shortages of professionals skilled in data analysis and infection control can reduce the effective utilization of deployed solutions. Concerns regarding data privacy and the secure handling of sensitive patient information also act as restraints in many healthcare environments.

Request Free Sample

Infection Surveillance Solutions Market: Report Scope

Infection Surveillance Solutions Market: Segmentation

​The Infection Surveillance Solutions market is segmented by product and services, type, end-user, and region.

By Product and Services, the infection surveillance solutions market includes services and software. The software segment is likely to register the highest growth rate over the forecast time period because of the demand for real-time analysis capabilities, flexible configurations, and seamless integration with electronic health records for efficient data collection, analytics, and reporting. The software segment is further bifurcated into on-premises and web-based.

By Type, the global infection surveillance solutions market includes surgical site infections, bloodstream infections, urinary tract infections, and others (pulmonary and antimicrobial resistance bacteria). Urinary tract infections (UTI) are estimated to hold a substantial market share in the upcoming years due to their high prevalence in healthcare settings and the critical need for continuous monitoring, early detection, and prevention strategies.

By End-User, the global market includes long-term care centers, hospitals, and others (clinics and ambulatory surgical centers). Hospitals are anticipated to exhibit the highest CAGR along with holding the dominant share of the global infection surveillance solutions market over the forecast period. This can be attributed to the growing geriatric population, high preference for hospitals by patients, and more efficient treatment of healthcare-associated infections in hospitals.

Infection Surveillance Solutions Market: Regional Analysis

Why will North America continue to dominate the global market during the projection period?

North America leads the Infection Surveillance Solutions market primarily due to its advanced healthcare infrastructure, stringent regulatory standards for infection control, and strong emphasis on patient safety. The United States, in particular, demonstrates high adoption rates driven by the significant incidence of healthcare-acquired infections and the widespread integration of healthcare IT solutions. The presence of major industry players and continuous investment in digital health technologies further reinforce the region’s leadership and set benchmarks for surveillance capabilities that influence global market development and innovation.

Europe represents a significant market for infection surveillance solutions, with countries like the United Kingdom, Germany, and France investing in advanced surveillance technologies to combat HAIs. The region's strong focus on patient safety and infection control in healthcare settings contributes to the growing adoption of these solutions.

The Asia-Pacific region is experiencing rapid growth in the infection surveillance solutions market, attributed to the high prevalence of infectious diseases, expanding healthcare services, and a growing emphasis on infection control measures. Countries such as China, Japan, India, and Australia are witnessing increased demand for advanced surveillance technologies in healthcare facilities to monitor and control infections effectively. The region's dense population and rising government healthcare spending further support market expansion.

Infection Surveillance Solutions Market: Competitive Players

Some major players in the global infection surveillance solutions market are:

• Premier
• Becton
• Dickinson and Company
• Wolters Kluwer
• Gojo Industries
• Atlas Medical Software
• RL Solutions
• Baxter International
• Hygreen
• Deb Group
• Truven Health Analytics

Segments Covered

The global infection surveillance solutions market is segmented as follows:

By Product and Services

• Software
  • On-Premises
  • Web-Based
• Services

By Type

• Surgical Site Infections (SSI)
• Blood Stream Infections (BSI)
• Urinary Tract Infections (UTI)
• Others (Pulmonary and antimicrobial resistance bacteria)

By End-User

• Long-Term Care Centers
• Hospitals
• Others (Clinics and ambulatory surgical centers)

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America